FDA clears Micrus's MicroCoil System:
This article was originally published in Clinica
Micrus has received 510(k) clearance from the US FDA to market its ACT MicroCoil System for the minimally invasive treatment of cerebral aneurysms. The system uses Micrus's MicruSphere Technology which enables the coil to form a spherical shape within the aneurysm. The Mountain View, California-based company claims that this provides greater stability of the coil mass within the treated aneurysm than devices currently on the market. The company CE-marked the device earlier this year.